| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 42 |
| 1 | INTERFERON BETA-1A | 42 |
| 2 | ETANERCEPT | 31 |
| 3 | GABAPENTIN | 28 |
| 4 | PREGABALIN | 26 |
| 5 | PREDNISONE | 19 |
| 6 | METOPROLOL | 18 |
| 7 | METOPROLOL TARTRATE | 18 |
| 8 | OMEPRAZOLE MAGNESIUM | 17 |
| 9 | ASPIRIN | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 1 | HYDROCODONE BITARTRATE AND IBUPROFEN | 1 | 0.0021 |
| 2 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0016 |
| 3 | PIOGLITAZONE AND METFORMIN HYDROCHLORIDE | 2 | 0.0016 |
| 4 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 5 | MEPROBAMATE | 1 | 0.0008 |
| 6 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 7 | AZELASTINE HCL | 1 | 0.0007 |
| 8 | WHITE PETROLATUM | 1 | 0.0007 |
| 9 | VUTRISIRAN | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 61 |
| 1 | Benzodiazepine [EPC] | 44 |
| 2 | Interferon beta [EPC] | 43 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 43 |
| 4 | Corticosteroid [EPC] | 29 |
| 5 | Integrin Receptor Antagonist [EPC] | 21 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 21 |
| 7 | Proton Pump Inhibitor [EPC] | 21 |
| 8 | Provitamin D2 Compound [EPC] | 21 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 21 | 0.0007 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 4 | 0.0005 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Barbiturate [EPC] | 3 | 0.0003 |
| 6 | Integrin Receptor Antagonist [EPC] | 21 | 0.0002 |
| 7 | Interferon beta [EPC] | 43 | 0.0002 |
| 8 | Interleukin-17A Antagonist [EPC] | 8 | 0.0002 |
| 9 | Aluminum Complex [EPC] | 5 | 0.0002 |